NCT02795988 2025-04-16
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Imugene Limited
Phase 1/2 Completed
Imugene Limited
Abramson Cancer Center at Penn Medicine
Medical College of Wisconsin
Merck KGaA, Darmstadt, Germany
AstraZeneca
University Hospital Tuebingen